Compare Boston Scientific Corporation (BSX) vs Home Depot Inc (HD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs Home Depot Inc — how do they compare? Boston Scientific Corporation trades at $42.65 (market cap $66.37B), while Home Depot Inc trades at $339 (market cap $336.77B). The key difference: Home Depot Inc is far larger — about 5.1× Boston Scientific Corporation's market cap, and Home Depot Inc pays a 2.76% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | HD | |
|---|---|---|
Market Cap | $66.37B | $336.77B |
Sector | Health | Consumer Cyclical |
52-Week High | $108.14 | $423.42 |
52-Week Low | $42.63 | $297.51 |
Enterprise Value | $75.94B | $398.32B |
Dividend Yield | — | 2.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Boston Scientific (BSX) trades at $44.65, down 0.27% with bearish technical signals despite strong fundamentals. The company delivered three consecutive earnings beats with Q3-Q1 2026 EPS exceeding expectations, while revenue grew to $20.07B in 2025 with improving profit margins. Technical indicators show bearish momentum with support at $44 and resistance at $45, though Wall Street maintains 88% buy rating with $70.20 consensus target.
BSX presents a compelling value opportunity with attractive valuation multiples (P/E 18.68, P/S 3.24) and robust financial health, though near-term headwinds include competitive pressures in key segments and recent stock price decline of nearly 60% from 2025 highs. The strong analyst consensus suggests significant upside potential if execution improves.
Home Depot (HD) trades at $337.11, down 1.8% on the day, with a bearish technical signal and mixed earnings history. The stock shows strong profitability with a net margin of 8.41% and ROE of 128.38%, but faces margin compression and weak big-ticket demand. Recent news highlights institutional selling and concerns over rising mortgage rates impacting home improvement spending.
The outlook is cautious due to near-term headwinds, but analyst consensus remains bullish with a $370.59 price target. Risks include housing market sensitivity and competitive pressures, while opportunities lie in Pro segment growth and dividend stability. Long-term prospects depend on economic resilience and execution against margin challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →
